Form 4: Calumet Director Amy Schumacher Receives Equity Grant

Calumet, Inc. Director Amy M Schumacher was granted 1,042 Restricted Stock Units, with varying vesting schedules, as reported in a recent SEC Form 4 filing.

Summary

• Amy M Schumacher, a Director of Calumet, Inc. (CLMT), acquired a total of 1,042 Restricted Stock Units (RSUs) on February 24, 2026.
• One grant consisted of 782 RSUs, which are 100% vested and will be settled upon the earlier of a date specified by the reporting person or her termination date.
• A second grant involved 260 RSUs, issued pursuant to the Deferred Compensation Plan. These units will also be settled upon the earlier of a date specified by the reporting person or her termination date, with 25% vesting annually beginning on July 1, 2027.
• Each Restricted Stock Unit is economically equivalent to one share of Calumet, Inc. common stock, par value $0.01 per share.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive development for corporate governance, as it aligns the director's long-term interests with shareholder value through equity compensation, though it does not reflect operational performance.

Positives

• The grant of Restricted Stock Units to a director aligns management's long-term interests with those of shareholders, promoting sustained company performance.
• The 782 RSUs are 100% vested upon grant, providing immediate equity interest.

Risks

• The value of the Restricted Stock Units is tied to the future market price of Calumet, Inc. common stock, which can fluctuate.
• The 260 RSUs are subject to a vesting schedule, meaning the director must remain with the company for a period to fully realize the benefit, posing a risk of forfeiture if employment terminates before vesting.

Future Outlook

The vesting schedule for a portion of the granted Restricted Stock Units extends into future years, specifically starting July 1, 2027, which indicates a long-term incentive structure for the director.

Industry Context

StockSavvy.ai notes that equity grants to directors are a common and widely accepted practice in corporate governance across various industries. This mechanism is designed to align the financial interests of company leadership with the long-term performance and shareholder value of the company.

Comparison to Industry Standards

• Equity compensation, such as Restricted Stock Units, for non-employee directors is a standard practice across publicly traded companies, including those in the energy and specialty products sectors where Calumet, Inc. operates.
• The structure of vesting over several years for a portion of the grant is also typical, aiming to retain talent and incentivize sustained performance.

Corporate Governance

Related Party Transactions

• The grant of Restricted Stock Units to Amy M Schumacher, a Director, constitutes a related party transaction, which is a standard form of compensation for board members.

Stakeholder Impact

• Shareholders: Potential positive impact due to increased alignment of director's interests with long-term company performance and shareholder value.
• Employees: No direct impact mentioned for general employees, but reflects the company's compensation philosophy for leadership.

Next Steps

• Settlement of the 782 fully vested Restricted Stock Units upon the earlier of the specified date or the reporting person's termination.
• Commencement of vesting for the 260 Restricted Stock Units on July 1, 2027, with 25% vesting annually thereafter.

Key Dates

Keywords

Calumet, CLMT, Form 4, Restricted Stock Units, RSU, Director, Equity Grant, Insider Transaction, Compensation, Corporate Governance